Clinical trial: Two drugs for advanced melanoma
(National Institutes of Health) UPDATED 2008-11-23
This is a study to determine if a combination of the drugs dacarbazine and Genasense is significantly better than dacarbazine plus a placebo in patients with advanced melanoma who have not yet undergone chemotherapy. This international study is currently recruiting adults with advanced melanoma who also have low baseline LDH levels.
Read full story >
See all Skin Cancer News